Literature DB >> 713716

The incorporation of orally administered radiolabeled dihomo gamma-linolenic acid (20 : 3 omega 6) into rat tissue lipids and its conversion of arachidonic acid.

A G Hassam, M A Crawford.   

Abstract

Radioactivity from orally administered radiolabeled dihomo-gamma-linolenic acid (20 : 3 omega 6) was recovered from the liver, plasma and brain lipid fractions. After administration the fatty acid was metabolized to arachidonic acid, the 22 carbon chain length fatty acid, and was also beta-oxidized. However, 22 hr after administration of [1-14C] 20 : 3 between one-third and one-half of the recovered radioactivity was still associated with dihomo-gamma-linolenic acid in the liver and plasma lipid fractions. Orally administered dihomo-gamma-linolenic acid is incorporated into lipid fractions and is, therefore, available in the metabolic pool for PGE1 synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 713716     DOI: 10.1007/bf02533479

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  11 in total

1.  On the origin of unsaturated fatty acids in clostridia.

Authors:  H GOLDFINE; K BLOCH
Journal:  J Biol Chem       Date:  1961-10       Impact factor: 5.157

2.  Synthesis and metabolism of polyunsaturated acids.

Authors:  J F MEAD
Journal:  Fed Proc       Date:  1961-12

3.  Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors.

Authors:  A Danon; M Heimberg; J A Oates
Journal:  Biochim Biophys Acta       Date:  1975-06-23

4.  The incorporation of orally fed radioactive γ-linolenic acid and linoleic acid into the liver and brain lipids of suckling rats.

Authors:  A G Hassam; A J Sinclair; M A Cramwford
Journal:  Lipids       Date:  1975-07       Impact factor: 1.880

5.  Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.

Authors:  A L Willis; K Comai; D C Kuhn; J Paulsrud
Journal:  Prostaglandins       Date:  1974-12-25

6.  Incorporation of radioactive polyunsaturated fatty acids into liver and brain of developing rat.

Authors:  A J Sinclair
Journal:  Lipids       Date:  1975-03       Impact factor: 1.880

7.  The differential incorporation of labelled linoleic, gamma-linolenic, dihomo-gamma-linolenic and arachidonic acids into the developing rat brain.

Authors:  A G Hassma; M A Crawford
Journal:  J Neurochem       Date:  1976-10       Impact factor: 5.372

8.  The effect of dihomo-gamma-linolenic acid (20: 3,n-6) on the composition of phospholipid fatty acids in the liver of rats deficient in essential fatty acids.

Authors:  A G Hassam
Journal:  Br J Nutr       Date:  1978-07       Impact factor: 3.718

9.  Antithrombotic potential of dihomo-gamma-linolenic acid in man.

Authors:  P B Kernoff; A L Willis; K J Stone; J A Davies; G P McNicol
Journal:  Br Med J       Date:  1977-12-03

10.  Metabolism of gamma-linolenic acid in essential fatty acid-deficient rats.

Authors:  A G Hassam; J P Rivers; M A Crawford
Journal:  J Nutr       Date:  1977-04       Impact factor: 4.798

View more
  5 in total

1.  In vivo incorporation of labeled fatty acids in rat liver lipids after oral administration.

Authors:  J Leyton; P J Drury; M A Crawford
Journal:  Lipids       Date:  1987-08       Impact factor: 1.880

2.  The effects of trans fatty acids on fatty acyl delta 5 desaturation by human skin fibroblasts.

Authors:  M D Rosenthal; M A Doloresco
Journal:  Lipids       Date:  1984-11       Impact factor: 1.880

3.  [Comparison of the effect of linolenic acid and eicosapentaenoic acid on prostaglandin biosynthesis and thrombocyte function in humans].

Authors:  O Adam; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1986-03-17

4.  Metabolism of linoleic acid in the cat.

Authors:  A J Sinclair; J G McLean; E A Monger
Journal:  Lipids       Date:  1979-11       Impact factor: 1.880

5.  In vivo and in vitro biotransformation of the lithium salt of gamma-linolenic acid by three human carcinomas.

Authors:  R de Antueno; M Elliot; G Ells; P Quiroga; K Jenkins; D Horrobin
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.